Re: Abiraterone and Increased Survival in Metastatic Prostate Cancer

被引：0
|
作者：
Richie, Jerome P. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Cambridge, MA 02138 USA
来源：
EUROPEAN UROLOGY | 2011年 / 60卷 / 04期
关键词：
D O I：
10.1016/j.eururo.2011.07.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：871 / 871
页数：1
相关论文
共 50 条
  • [21] Re: Darolutamide and Survival in Metastatic, Hormonesensitive Prostate Cancer
    Vilaseca, Antoni
    Ribal, Maria J.
    EUROPEAN UROLOGY, 2022, 82 (05) : 573 - 573
  • [22] Abiraterone shows promise in metastatic prostate cancer
    不详
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (18) : 3129 - 3129
  • [23] Improved Survival in advanced or metastatic Prostate Cancer for initial Androgen Deprivation by additional Abiraterone
    Carl, Cedric Oliver
    Schwarz, Rudolf
    Petersen, Cordula
    STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (03) : 266 - 268
  • [24] Abiraterone plus prednisone improves survival in metastatic castration-resistant prostate cancer
    Tagawa, Scott T.
    Beltran, Himisha
    ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (06) : 785 - 786
  • [25] Abiraterone improves survival in advanced prostate cancer
    Lyon, Sue
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2010, 71 (11) : 611 - 611
  • [26] Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
    Ryan, Charles J.
    Smith, Matthew R.
    de Bono, Johann S.
    Molina, Arturo
    Logothetis, Christopher J.
    de Souza, Paul
    Fizazi, Karim
    Mainwaring, Paul
    Piulats, Josep M.
    Ng, Siobhan
    Carles, Joan
    Mulders, Peter F. A.
    Basch, Ethan
    Small, Eric J.
    Saad, Fred
    Schrijvers, Dirk
    Van Poppel, Hendrik
    Mukherjee, Som D.
    Suttmann, Henrik
    Gerritsen, Winald R.
    Flaig, Thomas W.
    George, Daniel J.
    Yu, Evan Y.
    Efstathiou, Eleni
    Pantuck, Allan
    Winquist, Eric
    Higano, Celestia S.
    Taplin, Mary-Ellen
    Park, Youn
    Kheoh, Thian
    Griffin, Thomas
    Scher, Howard I.
    Rathkopf, Dana E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (02): : 138 - 148
  • [27] Use and security analysis of abiraterone in metastatic prostate cancer
    Dolores Alvarado-Fernandez, Maria
    Vazquez-Real, Miguel
    Marcos Rodriguez, Jose Antonio
    Santana Martinez, Sara
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 280 - 280
  • [28] LONG SURVIVAL WITH ABIRATERONE ACETATE IN AN ELDERLY PATIENT WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Macrini, Serena
    Poti, Giulia
    Giacinti, Silvana
    Bassanelli, Maria
    Roberto, Michela
    Aschelter, Anna Maria
    Marchetti, Paolo
    ANTICANCER RESEARCH, 2017, 37 (04) : 2085 - 2085
  • [29] Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer
    de Wit, Ronald
    de Bono, Johann
    Sternberg, Cora N.
    Fizazi, Karim
    Tombal, Bertrand
    Wuelfing, Christian
    Kramer, Gero
    Eymard, Jean-Christophe
    Bamias, Aristotelis
    Carles, Joan
    Iacovelli, Roberto
    Melichar, Bohuslav
    Sverrisdottir, Asgerdur
    Theodore, Christine
    Feyerabend, Susan
    Helissey, Carole
    Ozatilgan, Ayse
    Geffriaud-Ricouard, Christine
    Castellano, Daniel
    de Wit, Ronald
    de Bono, Johann
    Sternberg, Cora N.
    Fizazi, Karim
    Tombal, Bertrand
    Wulfing, Christian
    Kramer, Gero
    Eymard, Jean-Christophe
    Bamias, Aristotelis
    Carles, Joan
    Iacovelli, Roberto
    Melichar, Bohuslav
    Sverrisdottir, Asgerour
    Theodore, Christine
    Feyerabend, Susan
    Helissey, Carole
    Ozatilgan, Ayse
    Geffriaud-Ricouard, Christine
    Castellano, Daniel
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (26): : 2506 - 2518
  • [30] Use of abiraterone acetate in advanced metastatic prostate cancer
    Marquez Fernandez, E.
    Marmesat Rodas, B.
    Quesada Sanz, M. P.
    Gallego Galisteo, M.
    Ramos Baez, J. J.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 994 - 994
12345